Home > Products > Pharmaceutical intermediates



CasNo: 3516-95-8
MF: C15H14O2
Appearance: Slightly yellow crystals
From the aerial parts of Pepermia obtusi...
Chagas disease represents one of several...
We describe a novel reaction sequence fo...
The transfer hydrogenation of flavanones...
Biotransformation is an alternative with...
Acetylcholinesterase (AChE) inhibitors a...
Eight fungal strains (Penicillium raistr...

2-((Z)-3-hydroxy-3-phenylacryloyl)phenyl methylphenylcarbamate


2'-hydroxy-3-phenylpropiophenone


N-methyl-N-phenyl-3-phenylpropanamide


salicylic acid
| Conditions | Yield |
|---|---|
|
With water; sodium hydride; In tetrahydrofuran; for 24h; Reflux;
|
42% 42% |

Flavanone


(E)-2'-hydroxy-chalcone


2'-hydroxy-3-phenylpropiophenone
| Conditions | Yield |
|---|---|
|
With Rhodococcus sp. DSM 364; In acetone; at 28 ℃; for 168h; Microbiological reaction;
|
30% 13% |

Flavanone

2-hydroxychalcone

2-(5-phenyl-4,5-dihydroisoxazol-3-yl)phenol

(E)-2'-hydroxy-chalcone

1-(2-hydroxyphenyl)-3-phenyl-1-propanol

1-[2-(2-dimethylamino-ethoxy)-phenyl]-3-phenyl-propan-1-one

6-phenethyl-3,4-dihydro-2H-benzo[b][1,5]oxazocin-3-ol

2-benzyl-2-methoxy-benzofuran-3-one